Pregabalin Capsule 75 mg (Pregabalin)

Adult dose

This medication should be taken as pregabalin with a total daily dose divided into two oral doses regardless of meals. 1. Neuropathic pain - Peripheral neuropathic pain: Starting dose of 150 mg/day, can be increased to 300 mg/day within 3 to 7 days, and thereafter can be increased up to 600 mg/day at 7-day intervals. - Central neuropathic pain: Starting dose of 150 mg/day, and increased to 300 mg/day after one week.

Child dose

Safety and efficacy data are insufficient for pediatric patients under 12 years of age and adolescents aged 12 to 17, thus administration is not recommended.

This medication may increase the risk of suicidal thoughts or behavior, so any mood changes or unusual behaviors during use should be reported to a healthcare professional immediately. The use of this medication is not recommended in individuals with allergies to any ingredient in this medication or genetic issues such as lactose intolerance. Diabetes patients should be cautious as weight gain may require adjustments to blood sugar control medications. If severe allergic reactions like angioedema occur, administration should be immediately stopped and medical advice should be sought. Elderly patients should be particularly cautious during initial use as they may be at risk for falls or injuries due to dizziness or drowsiness. Blurred vision or other eye symptoms may occur, and if these symptoms develop, the medication should be stopped, or healthcare professional should be consulted. Discontinuing this medication suddenly can lead to withdrawal symptoms such as insomnia, headache, and anxiety, so dosage should be gradually reduced as per healthcare provider's instructions. Due to the risk of drug abuse, patients with a history of mental illness or substance abuse should be monitored closely. Patients with decreased kidney function may require dosage adjustments. Patients with heart disease should use this medication with caution, particularly those with congestive heart failure. Caution should be taken when using this medication in combination with opioid analgesics as it may increase the risk of central nervous system depression. Patients with respiratory or neurological diseases, kidney disorders, or elderly patients have a higher risk of severe respiratory suppression, so consultation with a healthcare professional is recommended when taking this medication. Pregnant women should avoid this medication during early pregnancy due to the risk of fetal malformations, and women of childbearing potential should use effective contraception. Breastfeeding mothers should consider stopping breastfeeding or discontinuing the medication as it may affect infants through breast milk. Patients should be cautious when engaging in hazardous activities such as driving or operating machinery, as dizziness or drowsiness may occur due to this medication. In case of overdose, symptoms may include confusion, drowsiness, depression, and seizures, and immediate medical attention should be sought. This medication should be kept out of the reach of children, and transferring it to another container may cause accidents, so care should be taken.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headache, lightning headache, seizures, confusion, visual disturbances, paralysis.

Mild side effects

• Dizziness
• drowsiness
• confusion
• altered sense of direction
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, at room temperature between 15°C and 30°C. Storing it this way will help maintain the medication's effectiveness for a long time.

Appearance

Hard capsule with a reddish-brown upper part and a white lower part containing a white or pale yellow powder.

Package unit

30 capsules/bottle, 100 capsules/bottle